137 related articles for article (PubMed ID: 1356812)
1. Developmental changes in the effect of atrial natriuretic peptide on tissue cyclic GMP content and particulate guanylate cyclase activity of aorta, kidney and lung of rats.
Muraki T; Irie K; Uchida Y; Nomoto T
Eur J Pharmacol; 1992 Aug; 226(4):311-5. PubMed ID: 1356812
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
Waldman SA; Rapoport RM; Murad F
J Biol Chem; 1984 Dec; 259(23):14332-4. PubMed ID: 6150043
[TBL] [Abstract][Full Text] [Related]
6. An oxidized analog of alpha-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase.
Koyama S; Terai T; Inoue T; Inomata K; Tamura K; Kobayashi Y; Kyogoku Y; Kobayashi M
Eur J Biochem; 1992 Feb; 203(3):425-32. PubMed ID: 1346519
[TBL] [Abstract][Full Text] [Related]
7. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
8. Effect of exercise training on ANP receptors.
Suda K; Hagiwara H; Kotani Y; Kato K; Sasaki M; Izawa T; Komabayashi T
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):227-35. PubMed ID: 11913714
[TBL] [Abstract][Full Text] [Related]
9. Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide.
Potvin W; Varma DR
Br J Pharmacol; 1990 Jun; 100(2):341-7. PubMed ID: 1974161
[TBL] [Abstract][Full Text] [Related]
10. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human erythrocyte Na+/H+ exchange by soluble and particulate guanylate cyclase.
Petrov V; Lijnen P
Am J Physiol; 1996 Nov; 271(5 Pt 1):C1556-64. PubMed ID: 8944639
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently.
Arnal JF; el Amrani AI; Michel JB
Eur J Pharmacol; 1993 Jun; 237(2-3):265-73. PubMed ID: 8396039
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide-dependent phosphorylation of smooth muscle cell particulate fraction proteins is mediated by cGMP-dependent protein kinase.
Sarcevic B; Brookes V; Martin TJ; Kemp BE; Robinson PJ
J Biol Chem; 1989 Dec; 264(34):20648-54. PubMed ID: 2573602
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of atrial natriuretic peptide-induced cyclic GMP accumulation in the bovine endothelial cells with anti-atrial natriuretic peptide receptor antiserum.
Ishido M; Fujita T; Shimonaka M; Saheki T; Ohuchi S; Kume T; Ishigaki I; Hirose S
J Biol Chem; 1989 Jan; 264(1):641-5. PubMed ID: 2562841
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs.
Muramatsu M; Tyler RC; Gutkowska J; Klinger JR; Hill NS; Rodman DM; McMurtry IF
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1126-32. PubMed ID: 9227514
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
19. Hindlimb-suspension and spaceflight both alter cGMP levels in rat choroid plexus.
Carcenac C; Herbute S; Masseguin C; Mani-Ponset L; Maurel D; Briggs R; Guell A; Gabrion JB
J Gravit Physiol; 1999 Oct; 6(2):17-24. PubMed ID: 11543082
[TBL] [Abstract][Full Text] [Related]
20. Evaluating atrial natriuretic peptide-induced cGMP production by particulate guanylyl cyclase stimulation in vitro and in vivo.
Hamet P; Tremblay J
Methods Enzymol; 1991; 195():447-61. PubMed ID: 1709714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
